Abstract
INTRODUCTION: Rapidly growing nontuberculous mycobacteria (RGM) can produce numerous types of infections including cutaneous disease, lymphadenitis, disseminated disease and pulmonary infection. The management of pulmonary infection due to RGM has proved unusually difficult to treat because the organism is invariably resistant to traditional antituberculous drugs and has varying susceptibility to other antibiotics. We evaluated the clinical manifestations, treatment, and therapeutic outcomes of RGM pulmonary infection.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have